ArticleAnnals of medicine and surgery (2012)2026
Cavernous hemangioma: a rare case report in the maxillary sinus.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and Importance: Cavernous hemangiomas are rare vascular malformations of the maxillary sinus that present diagnostic and therapeutic dilemmas. Case Presentation: This case report presents a 52-year-old woman with a slowly enlarging, painless swelling over the right infra-nasal region, leading to gross facial deformation. Imaging studies revealed a large, diffuse radiopaque mass in the upper right posterior maxilla, with a differential diagnosis favoring fibrous dysplasia. The patient underwent surgical excision via hemimaxillectomy under general anesthesia. Histopathological examination revealed a cavernous hemangioma. No perceptible aesthetic sequelae or recurrence was observed at follow-up months after treatment. Clinical Discussion: In the maxillofacial area, it is a rare entity, with the intraosseous type being even rarer, accounting for less than 1% of all bony tumors. The mandible is the most commonly affected site, accounting for approximately two-third hemangiomas of the jaw. The clinical manifestations of maxillary cavernous hemangiomas are highly variable and often nonspecific, making diagnosis challenging. Conclusion: Cavernous hemangiomas should be included in the differential diagnosis of maxillary sinus lesions. Surgical excision is the treatment of choice and results in an excellent prognosis with low recurrence rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.